Summary
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. Guidance is locally reviewed for applicability to Northern Ireland and, where appropriate, is endorsed for implementation in health and social care. THE LOCAL REVIEW DOES NOT REASSESS THE CLINICAL AND COST EVIDENCE USED BY NICE IN FORMING ITS ADVICE. The Department’s link with NICE has ensured that Northern Ireland has access to up-to-date, independent, professional, evidence-based guidance on the value of health care interventions.
Documents
- Equality Questionnaire - NICE Clinical Guideline Pathway NGs 244-245
- Draft Equality Screening performa - NICE Clinical Guideline Pathway NGs 244-245
Consultation description
Guidance for the consultation can be found on the NG244 - Asthma pathway (BTS, NICE, SIGN) and NG245 - Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)
The HSC (SQSD) 13/22 circular provides details of the process for the endorsement, implementation, monitoring and assurance of NICE Clinical Guidelines in Northern Ireland
In order to meet the timescales set out in the circular, the closing date for responses is 9 January 2025.
Ways to respond
Consultation closed — responses are no longer being accepted.